Shandong Wohua Pharmaceutical Co., Ltd.

Shenzhen Stock Exchange 002107.SZ

Shandong Wohua Pharmaceutical Co., Ltd. EPS (Diluted) for the year ending December 31, 2023: USD 0.01

Shandong Wohua Pharmaceutical Co., Ltd. EPS (Diluted) is USD 0.01 for the year ending December 31, 2023, a -48.84% change year over year. EPS (Diluted) reflects the company's earnings per share adjusted for the potential dilution that could occur if all convertible securities were converted to common stock, providing a more conservative profitability measure.

Shandong Wohua Pharmaceutical Co., Ltd. EPS (Diluted) for the year ending December 31, 2022 was USD 0.03, a -37.52% change year over year.
Shandong Wohua Pharmaceutical Co., Ltd. EPS (Diluted) for the year ending December 31, 2021 was USD 0.04, a -7.21% change year over year.
Shandong Wohua Pharmaceutical Co., Ltd. EPS (Diluted) for the year ending December 31, 2020 was USD 0.05, a 94.54% change year over year.
Shandong Wohua Pharmaceutical Co., Ltd. EPS (Diluted) for the year ending December 31, 2019 was USD 0.02, a 106.77% change year over year.

Key data

Date	EPS (Diluted)	Shares (Diluted, Weighted)	Shares (Basic, Weighted)	Revenue

Shenzhen Stock Exchange: 002107.SZ

Shandong Wohua Pharmaceutical Co., Ltd.

CEO	Ms. Yingzi Zeng
IPO Date	Jan. 24, 2007
Location	China
Headquarters	No. 3517 Liyuan Street
Employees	1,353
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies

Description

Shandong Wohua Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in China. It offers Xinkeshu tablets, Naoxueshu oral solutions, Tongluo Huayu capsules, and oral liquids for cardiovascular and cerebrovascular; respiratory system drugs; medicines for women and children; urinary system drugs; digestive system drugs; anti-rheumatic drugs; and drugs for soothe the nerves. The company is based in Weifang, China. Shandong Wohua Pharmaceutical Co., Ltd. is a subsidiary of Beijing Zhongzheng Wanrong Investment(Group) Co., Ltd.

Key trends

Past 5 years